Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new page revision, v3.3.4, was added and the previous revision, v3.3.3, was removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:36:36.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Florida location under Locations and updated the page revision to v3.3.3. Removed the older Florida Locations entry and the HHS Vulnerability Disclosure link.
    Difference
    0.4%
    Check dated 2025-12-23T20:59:55.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.2.0 to v3.3.2; no user-facing content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:07.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Branding and navigation updates add references to the Moffitt Cancer Center Clinical Trials website and related entities, along with helpful links; a government funding operating-status notice was removed.
    Difference
    0.6%
    Check dated 2025-11-18T07:22:20.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated study record dates: Enrollment (Actual) 13 and Study Completion (Actual) 2025-08-21, plus Last Update Posted 2025-10-01. The rest of the study details appear unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T21:32:41.000Z thumbnail image
  8. Check
    107 days ago
    Change Detected
    Summary
    Core content and status/version information updated: old recruitment/status indicators removed; newer operating status notice and updated dates/revision added.
    Difference
    4%
    Check dated 2025-10-06T06:55:34.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.